1. Home
  2. CMND vs BMRA Comparison

CMND vs BMRA Comparison

Compare CMND & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • BMRA
  • Stock Information
  • Founded
  • CMND 2017
  • BMRA 1971
  • Country
  • CMND Canada
  • BMRA United States
  • Employees
  • CMND N/A
  • BMRA N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CMND Health Care
  • BMRA Health Care
  • Exchange
  • CMND Nasdaq
  • BMRA Nasdaq
  • Market Cap
  • CMND 6.0M
  • BMRA 11.2M
  • IPO Year
  • CMND N/A
  • BMRA N/A
  • Fundamental
  • Price
  • CMND $1.13
  • BMRA $0.57
  • Analyst Decision
  • CMND
  • BMRA
  • Analyst Count
  • CMND 0
  • BMRA 0
  • Target Price
  • CMND N/A
  • BMRA N/A
  • AVG Volume (30 Days)
  • CMND 56.1K
  • BMRA 908.0K
  • Earning Date
  • CMND 04-15-2025
  • BMRA 04-11-2025
  • Dividend Yield
  • CMND N/A
  • BMRA N/A
  • EPS Growth
  • CMND N/A
  • BMRA N/A
  • EPS
  • CMND N/A
  • BMRA N/A
  • Revenue
  • CMND N/A
  • BMRA $5,578,000.00
  • Revenue This Year
  • CMND N/A
  • BMRA N/A
  • Revenue Next Year
  • CMND N/A
  • BMRA N/A
  • P/E Ratio
  • CMND N/A
  • BMRA N/A
  • Revenue Growth
  • CMND N/A
  • BMRA 1.40
  • 52 Week Low
  • CMND $0.95
  • BMRA $0.24
  • 52 Week High
  • CMND $2.30
  • BMRA $1.27
  • Technical
  • Relative Strength Index (RSI)
  • CMND 39.96
  • BMRA 41.69
  • Support Level
  • CMND $1.05
  • BMRA $0.57
  • Resistance Level
  • CMND $1.16
  • BMRA $0.65
  • Average True Range (ATR)
  • CMND 0.06
  • BMRA 0.08
  • MACD
  • CMND -0.00
  • BMRA -0.03
  • Stochastic Oscillator
  • CMND 27.30
  • BMRA 7.50

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: